RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
Affiliations of authors: Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY (SC); Department of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (SC, JH); Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands (MJR, FHS); Tampere University, School of Health Sciences, Tampere, Finland (AA). carlssos@mskcc.org.
Sigrid
S
Carlsson
Affiliations of authors: Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY (SC); Department of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (SC, JH); Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands (MJR, FHS); Tampere University, School of Health Sciences, Tampere, Finland (AA).
Monique J
MJ
Roobol
Affiliations of authors: Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY (SC); Department of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (SC, JH); Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands (MJR, FHS); Tampere University, School of Health Sciences, Tampere, Finland (AA).
Fritz H
FH
Schröder
Affiliations of authors: Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY (SC); Department of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (SC, JH); Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands (MJR, FHS); Tampere University, School of Health Sciences, Tampere, Finland (AA).
Jonas
J
Hugosson
Affiliations of authors: Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY (SC); Department of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden (SC, JH); Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands (MJR, FHS); Tampere University, School of Health Sciences, Tampere, Finland (AA).
Anssi
A
Auvinen
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality*; D057832:Watchful Waiting
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen